Articles with "pfizer" as a keyword



Photo from wikipedia

The Pfizer Crystal Structure Database: An essential tool for structure‐based design at Pfizer

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Computational Chemistry"

DOI: 10.1002/jcc.26862

Abstract: Pfizer's Crystal Structure Database (CSDB) is a key enabling technology that allows scientists on structure‐based projects rapid access to Pfizer's vast library of in‐house crystal structures, as well as a significant number of structures imported… read more here.

Keywords: structure database; structure; pfizer; pfizer crystal ... See more keywords
Photo by libraryofcongress from unsplash

COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram

Sign Up to like & get
recommendations!
Published in 2021 at "Academic Radiology"

DOI: 10.1016/j.acra.2021.11.010

Abstract: Background Women who received a COVID-19 vaccination may display subclinical unilateral axillary lymphadenopathy on screening mammography, which can appear suspicious for malignancy, leading to additional diagnostic evaluation. Purpose To evaluate the prevalence of subclinical unilateral… read more here.

Keywords: pfizer; women received; axillary lymphadenopathy; vaccine ... See more keywords
Photo from wikipedia

Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of Medicine and Surgery"

DOI: 10.1016/j.amsu.2022.103420

Abstract: Introduction and importance: Messenger RNA vaccines, commonly known as mRNA vaccines, are the first COVID-19 vaccines that have been authorized and licensed in the United States. Two mRNA vaccines, BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) are… read more here.

Keywords: covid vaccine; case; bullous pemphigoid; pfizer ... See more keywords
Photo from wikipedia

A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Community Hospital Internal Medicine Perspectives"

DOI: 10.1080/20009666.2021.1954284

Abstract: ABSTRACT Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in December 2019, COVID-19 has caused a global pandemic associated with significant morbidity and mortality. After a year of advances in vaccine research… read more here.

Keywords: pfizer; covid vaccine; case; case guillain ... See more keywords
Photo from wikipedia

Updated efficacy and safety of entrectinib in patients with NTRK fusion-positive tumors: Integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz244.038

Abstract: Abstract Background Entrectinib is a systemic and CNS-active, potent inhibitor of TRKA/B/C and ROS1. Primary data from integrated efficacy and safety analyses (6 months’ follow-up) from entrectinib clinical trials have shown that entrectinib is a… read more here.

Keywords: research; pfizer; safety; advisory consultancy ... See more keywords
Photo by anniespratt from unsplash

SUNitinib with EVOfosfamide (TH-302) for G1/G2 metastatic pancreatic neuroendocrine tumours (pNETs) naïve for systemic treatment. The SUNEVO phase II trial of the Spanish task force group for neuroendocrine and endocrine tumours (GETNE)

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz256.004

Abstract: Abstract Background Sunitinib (SUN) is approved for the treatment of advanced progressive pNETs. Hypoxia induced by SUN could foster the activation of the prodrug evofosfamide (EVO), designed to release the DNA alkylator bromo-isophosphoramide mustard under… read more here.

Keywords: trial; pfizer ipsen; pfizer; accommodation expenses ... See more keywords
Photo from wikipedia

Differences in multikinase inhibitors (MKI) toxicity profile according to gender. A pooled analysis of three phase II trials with lenvatinib, pazopanib and sorafenib in patients (pts) with advanced gastroenteropancreatic (GEP) neuroendocrine tumours (NETs)

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz256.007

Abstract: Abstract Background There is a dearth of understanding of gender influence in targeted therapies toxicity. Increasing evidence suggests a possible different toxicity profile according to gender, but mostly retrospective studies in common tumors. Currently, data… read more here.

Keywords: pfizer; according gender; toxicity; novartis ... See more keywords
Photo from wikipedia

1236. Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Healthy Infants in the United States

Sign Up to like & get
recommendations!
Published in 2020 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofaa439.1421

Abstract: A 20-valent pneumococcal conjugate vaccine (PCV20) is being developed to extend protection against pneumococcal disease beyond that of the 13-valent pneumococcal vaccine (PCV13). This is the first safety and immunogenicity study of PCV20 in healthy… read more here.

Keywords: research; pfizer; pcv20; pfizer employee ... See more keywords
Photo from wikipedia

1580. In Vitro Activity of Ceftazidime-Avibactam Against Enterobacterales and Pseudomonas aeruginosa Collected in Latin America as part of the ATLAS Global Surveillance Program, 2017-2019

Sign Up to like & get
recommendations!
Published in 2020 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofaa439.1760

Abstract: Ceftazidime-avibactam (CAZ-AVI) is a β-lactam/non-β-lactam β-lactamase inhibitor combination with in vitro activity against Enterobacterales (Ent) and Pseudomonas aeruginosa (Psa) carrying Class A, C and some Class D β-lactamases. We examined the in vitro activity of… read more here.

Keywords: caz avi; pfizer; employee; vitro activity ... See more keywords
Photo from wikipedia

1604. Cost-Effectiveness of Ceftazidime-Avibactam for Patients with Hospital-Acquired Pneumonia Caused by Multi-Drug Resistant Enterobacteriaceae or Pseudomonas in China

Sign Up to like & get
recommendations!
Published in 2020 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofaa439.1784

Abstract: To estimate the cost-effectiveness of ceftazidime-avibactam (CAZ-AVI) for the treatment of hospital-acquired pneumonia (HAP) including ventilator-associated pneumonia (VAP) caused by multi-drug resistant enterobacteriaceae (MDRE) or MDR pseudomonas aeruginosa (MDRPA) in China. A previously published patient-level… read more here.

Keywords: caz avi; effectiveness ceftazidime; pfizer; cost ... See more keywords
Photo by paipai90 from unsplash

1353. Incidence of Lyme Borreliosis in Germany: Exploring Observed Trends Over Time Using Public Surveillance Data, 2016–2020.

Sign Up to like & get
recommendations!
Published in 2022 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofac492.1182

Abstract: Abstract Background Lyme borreliosis (LB) is an infectious, vector-borne disease caused by the spirochete Borrelia burgdorferi sensu lato and mainly transmitted by the Ixodes species ticks. Public surveillance of LB occurs in 9 of 16… read more here.

Keywords: stocks bonds; incidence; 000 person; pfizer ... See more keywords